The IHU Infiny is a consortium coordinated by the CHRU de Nancy, bringing together 9 joint research units (Université de Lorraine, INSERM, Université de Lorraine-CNRS, Institut Pasteur-INSERM) and 3 clinical investigation centers of the CHRU de Nancy.
Management Board
Representatives of the founding members:
Arnaud VANNESTE
Director General of the Nancy University Hospital, Chairman of the IHU Management Board
Marc DEBOUVERIE
Chairman of the Commission Médicale d’Établissement, Nancy University Hospital
Hélène BOULANGER
President of the University of Lorraine
Claire TESSIER
Deputy General Director – Research, Projects, and Partnerships Department, University of Lorraine
Eric SIMON
Regional Delegate, INSERM
Catherine SCHUSTER
Scientific Advisor, INSERM
Mathieu KLEIN
President of the Greater Nancy Metropolitan Area
Christophe CHOSEROT
Vice-President of the Greater Nancy Metropolitan Area
Jean-Marc SALZARD
Chairman of the ID+ Foundation
Qualified personalities and associate members
Jean-Paul TORRIS
Advisor to the Chairman of Savencia
Pierre MALINGREY
Chairman of the Supervisory Board, Quipment
Anne BUISSON
Director of AFA Crohn’s RCH Association
Executive Committee

Christian RABAUD
Interim Director of the IHU
Professor and Hospital Practitioner, Nancy University Hospital

Benoît CHASSAING
Director of IHU Fundamental Research Department
Dr INSERM, Head of Microbiome-Host Interactions Lab, Institut Pasteur
Dr Bénédicte CARON
Director of IHU Clinical Research Department
MCU-PH, Nancy University Hospital
Emilie PAWLAK
Secretary-General
Aurélie FRENTZ
Director of Resources and Partnerships
International Scientific Advisory Board (SAB)
This committee consists of six leading scientists from academia or industry, independent of the IHU, with expertise in inflammatory bowel diseases, nutrition, or public health.
The committee is consulted on key scientific priorities and the annual action program prior to their approval by the IHU Management Board. It also conducts an annual review of scientific activities and provides actionable recommendations to the Management Board to support the national, European, and international development of the IHU Infiny’s initiatives.
Raja ATREYA
Professor and Gastroenterologist, University of Erlangen-Nuremberg
Richard FRACKOWIAK
Professor, Neurologist and Neuroscientist, EPF Lausanne Emeritus, University College London
Ailsa HART
Professor, Director St Mark’s Hospital, London
Marietta IACUCCI
Professor, Gastroenterologist, University College Cork, Ireland
Arthur KASER
Professor, Gastroenterologist, Cambridge University Hospitals
Saurabh MEHANDRU
Associate Professor, Gastroenterologist, Icahn School of Medicine at Mount Sinai, NY